Valniche 850MG Tablet (2’s) is a pharmaceutical product that contains Valganciclovir as its active ingredient, with each tablet delivering 450mg of this potent antiviral medication. Valganciclovir is primarily used in the treatment and prevention of cytomegalovirus (CMV) infections, particularly in immunocompromised patients, such as those undergoing organ transplantation or those with HIV/AIDS. The formulation of Valniche is designed to enhance the bioavailability of Valganciclovir, making it more effective in combating viral infections. This medication plays a crucial role in managing CMV retinitis, a serious eye infection that can lead to vision loss. Valniche 850MG Tablet is typically prescribed as part of a comprehensive treatment plan, and its use should be closely monitored by healthcare professionals to ensure optimal therapeutic outcomes.